Seegene USA

02/12/2024

FREE WEBINAR: The Triple Threat: SARS-CoV-2, influenza, and respiratory syncytial virus - What's different this respiratory season? Distinguishing between the three can be challenging based on symptoms alone. Find out how this year's respiratory season compares to the last in this free webinar sponsored by Seegene USA, Inc.

The Triple Threat: Has it changed since the last respiratory season?
Register »https://register.gotowebinar.com/register/4457873573785581401?__hstc=17452326.075f1f6cbe841d7f78da81b5805b2ffc.1707425896521.1707425896521.1707425896521.1&__hssc=17452326.1.1707430387541&__hsfp=1361505549&hsCtaTracking=337828e6-d0e5-4dcc-aa94-89ea63ce7825%7C5d43cdd0-4350-4bc2-bad3-f3e714e065c5

Presented by industry expert J. Kristie Johnson, PhD, D(ABMM)
February 28, 2024 | Time: 10:00 AM - 11:00 AM PST | 1:00pm EST

02/04/2024

World Cancer Day is Sunday, February 4! 🌎
Cervical cancer: Every year, nearly 12,000 women living in the U.S. will have cervical cancer. More than 4,000 women die per year from cervical cancer.
Novaplex™ HPV28* are designed to identify 19 high-risk and/or 28 unique low and high-risk HPV types in a single specimen including those that are known to cause cervical cancer.
Novaplex™ HPV HR* is suitable for HPV testing in all circumstances, meeting diverse region-specific identification needs. It allows more efficient turnaround time and fully automated workflow and is designed to provide comprehensive information.
*All Novaplex™ products are for Research Use Only. Not for use in diagnostic procedures.
»Learn More https://seegeneus.com/assays/human-papillomavirus-infection-hpv/

01/29/2024

Imagine a world free of diseases... A bold mission, right? 🌍🏥
Join us in supporting Dr. Jong Yoon Chun, CEO and founder of Seegene as they work towards making this vision a reality! 💪💉
Through the adoption of syndromic PCR molecular diagnostics and a partnership with Microsoft for digital transformation, they are revolutionizing the healthcare ecosystem and making a lasting impact. 🌟
»View Press Release
https://seegeneus.com/collaboration-with-microsoft/

08/05/2022

We are excited to announce that our team will be attending the International Conference on Emerging Infectious Diseases 2022 ( ) from Aug 7-10 in Atlanta, GA.
If you'd like to set up a meeting with us at the event, Contact us here: https://seegenetech.com/contact_us/

We look forward to having a wonderful discussion on and with fellow attendees!

07/26/2022

👋 Did you get a chance to stop by Seegene's Booth # 2261 at and learn more about our exciting offers for AACC attendees this year?
Don't forget to take a look at our molecular testing solutions (including Research Use Only PCR assays for Monkeypox, Tick-Borne, Drug Resistance, UTI, STI, and more)!
https://seegenetech.com/2022-aacc-clinical-lab-expo/

07/23/2022

Are you attending ?
✨We have some exciting offers for AACC attendees this year! ✨
Come by our Booth #2261 to learn more about our molecular testing solutions (including Research Use Only PCR assays for , Tick-Borne, Drug Resistance, UTI, STI, and more).
Learn more: https://seegenetech.com/2022-aacc-clinical-lab-expo/

06/29/2022

Seegene develops PCR test* designed to detect monkeypox virus
Press Release: https://seegenetech.com/seegene-develops-pcr-test-to-detect-monkeypox-virus/

*Available in the US for Research Use Only. Not for use in Diagnostic Procedures.

SEOUL, South Korea, June 28, 2022 /PRNewswire/ — Seegene Inc. (KQ965390), South Korea’s leading molecular diagnostics (MDx) company has developed a PCR test to detect the monkeypox virus. The Novaplex™ MPXV Assay, which specifically targets the monkeypox virus, was swiftly developed usin...

06/07/2022

The surge in Sexually Transmitted Infections:
According to the CDC, 1,579,885 cases of Chlamydia trachomatis infection were reported in 2020 during the pandemic.
https://t.co/XhKrU0LyTE

Contact us to learn more about our Novaplex™ Research Use STI Assay: https://seegenetech.com/contact_us/

STD Information from CDC. Facts, Statistics, Treatment, and Other Resources.

06/07/2022

Here is some useful information on from California Department of Public Health.

05/26/2022

The Seegene Novaplex™ SARS-CoV-2 Variant Assay (Research Use Only) is designed to detect new and emerging SARS-CoV-2 variants, in a single tube.



Learn more here: https://seegenetech.com/novaplex-sars-cov-2-variants-ii-assay/

05/19/2022

Our Novaplex™ SARS-CoV-2 Flu A/Flu B/RSV Assay (Research Use Only) is a multiplex real-time assay that allows researchers to amplify target nucleic acids for Influenza A virus, Influenza B virus, Human RSV and SARS-CoV-2 at the same time.

Learn more about the assay here:

https://seegenetech.com/novaplex_sars-cov-2_flua_flub_rsv_assay/

05/17/2022

Are you attending the 2022 Annual Conference?
Come meet our Seegene Technologies team at Booth #500 to learn more about our multiplex molecular assays and automation solutions for your laboratory!
Learn more: https://seegenetech.com/2022-aphl-annual-conference/